Phytogenix Ultimate Caralluma
Natural health product licensed in Canada
- Other names
- Slimquick Caralluma
- Licence holder
- Slimquick
- NPN or DIN-HM
- 80042372
- Status
- Inactive licence
- Licence date
- 17 May 2013
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Caralluma fimbriata Source : Sommité Extraction ratio : 12:1 Dry plant equivalent : 2.0004 g | 166.7 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Silice, Phosphate dicalcique, Croscarmellose de sodium, Maltodextrine, Stéarate de magnésium, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Comprimé | 2 days |
Uses authorised in Canada
Helps reduce appetite to complement weight management programs including healthy eating habits, a reduced calorie intake and increased physical exercise.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have a liver disorder or develop symptoms of liver trouble (such as abdominal pain, dark urine or jaundice), or if you have an iron deficiency.
Source
Official Health Canada record, licence 80042372
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.